SIS
DFTX

Strategic Investment Solutions’s Definium Therapeutics DFTX Stock Holding History

Strategic Investment Solutions’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6
Closed -$71 – 642
2025
Q3 		$71 Hold
6
– – ﹤0.01% 591
2025
Q2 		$39 Hold
6
– – ﹤0.01% 592
2025
Q1 		$35 Hold
6
– – ﹤0.01% 622
2024
Q4 		$42 Hold
6
– – ﹤0.01% 633
2024
Q3 		$34 Buy
+6
New +$42 ﹤0.01% 637
2023
Q4 		$22 Sell
6
-372
-98% -$1.12K ﹤0.01% 1110
2023
Q3 		$1.56K Buy
378
+372
+6,200% +$1.53K ﹤0.01% 696
2023
Q2 		$21 Hold
6
– – ﹤0.01% 864
2023
Q1 		$19 Buy
+6
New +$20 ﹤0.01% 1010

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Strategic Investment Solutions's DFTX Position: Q4 2025 in Review

Strategic Investment Solutions sold out of Definium Therapeutics (DFTX) in Q4 2025, closing a stake of 6 shares — an estimated $71 sold.

Strategic Investment Solutions first reported a position in DFTX in Q1 2023 and held it in 9 quarters. The position peaked at $1.56K in Q3 2023. 208 funds tracked by Wall St. Rank hold DFTX as of Q4 2025.

  • Strategic Investment Solutions reported no remaining Definium Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Strategic Investment Solutions sold 6 Definium Therapeutics shares in Q4 2025, an estimated $71.
  • Strategic Investment Solutions first reported a position in Definium Therapeutics in Q1 2023 and held it in 9 quarters.
  • Strategic Investment Solutions's Definium Therapeutics position peaked at $1.56K in Q3 2023.
  • 208 funds tracked by Wall St. Rank held Definium Therapeutics as of Q4 2025.

Based on Strategic Investment Solutions's 13F filing for Q4 2025, filed 27 Feb 2026.